|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.60 CHF | +0.08% |
|
-4.45% | +13.69% |
| 08-04 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
| 08-03 | Is Everything Under Control? |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 130.5 | 130.5 | 130.5 |
| Spread/Res. | -4.52% | -4.52% | -4.52% |
| Spread/Supp. | +2.13% | +10.27% | +27.44% |
| Support | 122 | 113 | 97.77 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions
